Showing 1 - 20 results of 47 for search 'Robin M. Warren', query time: 0.08s Refine Results
  1. 1
    Implementation of new tools for multidrug-resistant tuberculosis detection and control

    Implementation of new tools for multidrug-resistant tuberculosis detection and control by Robin M Warren

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Fighting an old disease with next-generation sequencing

    Fighting an old disease with next-generation sequencing by Anzaan Dippenaar, Robin M Warren

    Published 2015-03-01
    Get full text
    Article
  3. 3
    A threshold value for the time delay to TB diagnosis.

    A threshold value for the time delay to TB diagnosis. by Pieter W Uys, Robin M Warren, Paul D van Helden

    Published 2007-01-01
    Get full text
    Article
  4. 4
    Characterization of Mycobacterium orygis

    Characterization of Mycobacterium orygis by Nicolaas C. Gey van Pittius, Paul D. van Helden, Robin M. Warren

    Published 2012-10-01
    Get full text
    Article
  5. 5
    The <i>Mycobacterium smegmatis</i> HesB Protein, MSMEG_4272, Is Required for In Vitro Growth and Iron Homeostasis

    The <i>Mycobacterium smegmatis</i> HesB Protein, MSMEG_4272, Is Required for In Vitro Growth and Iron Homeostasis by Nandi Niemand Wolhuter, Lerato Ngakane, Timothy J. de Wet, Robin M. Warren, Monique J. Williams

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Identification and Characterisation of Nontuberculous Mycobacteria in African Buffaloes (<i>Syncerus caffer</i>), South Africa

    Identification and Characterisation of Nontuberculous Mycobacteria in African Buffaloes (<i>Syncerus caffer</i>), South Africa by Charlene Clarke, Tanya J. Kerr, Robin M. Warren, Léanie Kleynhans, Michele A. Miller, Wynand J. Goosen

    Published 2022-09-01
    Get full text
    Article
  7. 7
    Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis.

    Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis. by Danicke Willemse, Brandon Weber, Laura Masino, Robin M Warren, Salvatore Adinolfi, Annalisa Pastore, Monique J Williams

    Published 2018-01-01
    Get full text
    Article
  8. 8
    The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.

    The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks. by Frederick A Sirgel, Robin M Warren, Erik C Böttger, Marisa Klopper, Thomas C Victor, Paul D van Helden

    Published 2013-01-01
    Get full text
    Article
  9. 9
    Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.

    Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. by Frederick A Sirgel, Robin M Warren, Erik C Böttger, Marisa Klopper, Thomas C Victor, Paul D van Helden

    Published 2015-01-01
    Get full text
    Article
  10. 10
    Novel Cause of Tuberculosis in Meerkats, South Africa

    Novel Cause of Tuberculosis in Meerkats, South Africa by Sven D.C. Parsons, Julian A. Drewe, Nicolaas C. Gey van Pittius, Robin M. Warren, Paul D. van Helden

    Published 2013-12-01
    Get full text
    Article
  11. 11
    The MAGMA pipeline for comprehensive genomic analyses of clinical Mycobacterium tuberculosis samples

    The MAGMA pipeline for comprehensive genomic analyses of clinical Mycobacterium tuberculosis samples by Tim H. Heupink, Lennert Verboven, Abhinav Sharma, Vincent Rennie, Miguel de Diego Fuertes, Robin M. Warren, Annelies Van Rie

    Published 2023-11-01
    Get full text
    Article
  12. 12
    The Detection of Mutations and Genotyping of Drug-Resistant <i>Mycobacterium tuberculosis</i> Strains Isolated from Patients in the Rural Eastern Cape Province

    The Detection of Mutations and Genotyping of Drug-Resistant <i>Mycobacterium tuberculosis</i> Strains Isolated from Patients in the Rural Eastern Cape Province by Lindiwe M. Faye, Mojisola C. Hosu, Selien Oostvogels, Anzaan Dippenaar, Robin M. Warren, Ncomeka Sineke, Sandeep Vasaikar, Teke Apalata

    Published 2023-07-01
    Get full text
    Article
  13. 13
    Identifying nucleic acid-associated proteins in Mycobacterium smegmatis by mass spectrometry-based proteomics

    Identifying nucleic acid-associated proteins in Mycobacterium smegmatis by mass spectrometry-based proteomics by Nastassja L. Kriel, Tiaan Heunis, Samantha L. Sampson, Nico C. Gey van Pittius, Monique J. Williams, Robin M. Warren

    Published 2020-03-01
    Get full text
    Article
  14. 14
    Detection of Mycobacterium bovis in nasal swabs from communal goats (Capra hircus) in rural KwaZulu-Natal, South Africa

    Detection of Mycobacterium bovis in nasal swabs from communal goats (Capra hircus) in rural KwaZulu-Natal, South Africa by Deborah M. Cooke, Charlene Clarke, Tanya J. Kerr, Robin M. Warren, Carmel Witte, Carmel Witte, Michele A. Miller, Wynand J. Goosen

    Published 2024-02-01
    Get full text
    Article
  15. 15
    Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations

    Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations by Christian C. Otum, Emmanuel Rivière, Monique Barnard, Johannes Loubser, Monique J. Williams, Elizabeth M. Streicher, Annelies Van Rie, Robin M. Warren, Marisa Klopper

    Published 2023-06-01
    Get full text
    Article
  16. 16
    Novel Mycobacterium tuberculosis Complex Pathogen, M. mungi

    Novel Mycobacterium tuberculosis Complex Pathogen, M. mungi by Kathleen A. Alexander, Pete N. Laver, Anita L. Michel, Mark Williams, Paul D. van Helden, Robin M. Warren, Nicolaas C. Gey van Pittius

    Published 2010-08-01
    Get full text
    Article
  17. 17
    A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

    A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis. by Michael G Whitfield, Heidi M Soeters, Robin M Warren, Talita York, Samantha L Sampson, Elizabeth M Streicher, Paul D van Helden, Annelies van Rie

    Published 2015-01-01
    Get full text
    Article
  18. 18
    Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.

    Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa. by Elize Pietersen, Kim Anderson, Helen Cox, Keertan Dheda, Aihua Bian, Bryan E Shepherd, Timothy R Sterling, Robin M Warren, Yuri F van der Heijden

    Published 2023-01-01
    Get full text
    Article
  19. 19
    Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa

    Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa by Elize Pietersen, Kim Anderson, Helen Cox, Keertan Dheda, Aihua Bian, Bryan E. Shepherd, Timothy R. Sterling, Robin M. Warren, Yuri F. van der Heijden

    Published 2023-01-01
    Get full text
    Article
  20. 20
    Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa

    Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa by Sarah V. Leavitt, Karen R. Jacobson, Elizabeth J. Ragan, Jacob Bor, Jennifer Hughes, Tara C. Bouton, Tania Dolby, Robin M. Warren, Helen E. Jenkins

    Published 2021-03-01
    Get full text
    Article

Search Tools: